Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test.
Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don't get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections.
Scope of the Report:
This report focuses on the Zika Virus Testing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The Zika Virus Testing market is very concerted market; the revenue of top fourteen manufacturers accounts about 75% of the total revenue in 2017. The high-end products mainly come from USA and Europe.
2 The leading manufactures mainly are Chembio, Quest Diagnostics, ARUP Laboratories, Luminex Corporation and Simens. Chembio is the largest manufacturer; its revenue of global market exceeds 13% in 2017. The next is Quest Diagnostics and ARUP Laboratories
3 There are mainly two type product of Zika Virus Testing market: Molecular Test and Serologic Test.
4 Geographically, the global Zika Virus Testing market has been segmented into Latin America, North America, Europe, Asia-Pacific and RoW. The Latin America held the largest share in the Consumption market, its consumption volume of global market exceeds 50% in 2017. The next is North America.
The worldwide market for Zika Virus Testing is expected to grow at a CAGR of roughly 3.2% over the next five years, will reach 120 million US$ in 2023, from 96 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Quest Diagnostics
- ARUP Laboratories
- Luminex Corporation
- Abbott Molecular
- ELITechGroup Molecular Diagnostics
- EUROIMMUN US
- Creative Diagnostics
- Vela Diagnostics
- InBios International
- Altona Diagnostics
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Molecular Test
- Serologic Test
Market Segment by Applications, can be divided into
- Diagnostic Centers
- Pathology Labs
There are 15 Chapters to deeply display the global Zika Virus Testing market.
Chapter 1, to describe Zika Virus Testing Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Zika Virus Testing, with sales, revenue, and price of Zika Virus Testing, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Zika Virus Testing, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Zika Virus Testing market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Zika Virus Testing sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source